Driven by Science, Guided by Experience

After 35 years in pharma and biotech R&D, I bring a blend of scientific expertise and strategic insight.

At Sanifit Therapeutics, I led a amazing team and together we advanced SNF472—a first-in-class vascular calcification inhibitor—from drug discovery to the end Phase 3, supported by 11 venture capital firms, passionate private investors, and a fantastic panel of key opinion leaders.

Now, as a consultant, I am eager to share the insights and expertise I’ve gained to help drive innovative biopharmaceutical projects forward.